(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CARTILAGE FRAGMENTATION INHIBITOR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CARTILAGE FRAGMENTATION INHIBITOR

ST13

US500000086647603

Class

3, 5

Filing

86647603

Registration

5215443

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

54

Latest update

05/31/2026

Trademark type

Combined

Nice classes

3, 5

Filing date

06/01/2015

Registration date

05/30/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/04/2023

Last transaction

05/31/2026

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Supplemental Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

16

Owner location

Destelbergen, BE

Examiner

SHARPER JR, SAM

Law office

L80

Current location

TMEG LAW OFFICE 108

Mark description

The mark consists of the word "CARTILAGE" followed by the word "FRAGMENTATION", which is separated horizontally as if fractured, and followed by the word "INHIBITOR".

Holders and representatives

Holders

Bio Minerals N.V.
Bio Minerals N.V.

Representatives

Cheryl L. Burbach Erise IP, P.A.

Technical classification

Nice Classes

Class 3Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Cosmetic preparations for oral usefor structural improvement and protection of epidermal structures

Class 5

Pharmaceutical preparationsoral preparations for use in the prevention and/or treatment of cardiovascularmusculoskeletal and connective tissue related disorders; nutritional supplement preparations for medical use; vitamins and mineral preparations for medical use; dietary supplements for medical use

Publications

History of USPTO decisions and trademark events.

54 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/30/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/13/2026

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

04/13/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/13/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/13/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/13/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/13/2026

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

10/04/2023

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

10/04/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/04/2023

8.AF

REGISTERED - SEC. 8 (6-YR) FILED

05/25/2023

ES8R

TEAS SECTION 8 RECEIVED

05/25/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/30/2022

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

05/30/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/25/2017

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

04/24/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/21/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/20/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/20/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/04/2017

GNRT

NON-FINAL ACTION E-MAILED

01/04/2017

CNRT

NON-FINAL ACTION WRITTEN

01/04/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/20/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/20/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/20/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/14/2016

GNRT

NON-FINAL ACTION E-MAILED

07/14/2016

CNRT

NON-FINAL ACTION WRITTEN

07/14/2016

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

07/05/2016

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

06/07/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

05/25/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/18/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/12/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/12/2016

ALIE

ASSIGNED TO LIE

05/06/2016

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/25/2016

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/04/2016

GNSL

LETTER OF SUSPENSION E-MAILED

04/04/2016

CNSL

SUSPENSION LETTER WRITTEN

04/04/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

04/04/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/04/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

04/04/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/04/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/15/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/14/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/14/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/14/2015

GNRT

NON-FINAL ACTION E-MAILED

09/14/2015

CNRT

NON-FINAL ACTION WRITTEN

09/14/2015

DOCK

ASSIGNED TO EXAMINER

09/12/2015

DOCK

ASSIGNED TO EXAMINER

09/11/2015

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

06/09/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/08/2015

NWAP

NEW APPLICATION ENTERED

06/04/2015

Continuous trademark protection

Get notified about every new filing that threatens CARTILAGE FRAGMENTATION INHIBITOR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.